Hotline: Tocilizumab for RA

On February 3, 2010, the ACR released a Hotline on Tocilizumab for the Treatment of Rheumatoid Arthritis. Tocilizumab (Actemra) was approved by the FDA on January 8, 2010 for the treatment of rheumatoid arthritis. The U.S. approval was based on five pivotal trials and other experience (1-6). Tocilizumab has previously been approved for clinical use in Japan and Europe.  » Read this Hotline

• Access Past Hotlines

2009 Annual Report Marks 75th Year of Excellence

Review the achievements, and enjoy a final celebration of the ACR’s 75th Anniversary, in the 2009 annual report. The 2009 report not only offers information on the accomplishments of the College’s 75th year, but also provides a snapshot of the College—and the rheumatology community—throughout its history.  » Review the achievements of our 75th year.

• Review Past Annual Reports

The New www.rheumatology.org

Welcome to the redesigned Web site for the ACR, ARHP and REF. The new Web site includes a more robust search feature to provide easier access to information, quick access to tools and easier navigation.